COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,304 Articles (22,772 medRxiv, 8,532 bioRxiv)

Most recent first Previous |  Page 2403: Articles 24021-24030  | Next

Risk stratification as a tool to rationalize quarantine among health care workers exposed to COVID-19 cases - Evidence from a tertiary healthcare centre in India
Kaur, R., Kant, S., Bairwa, M., Kumar, A., Dhakad, S., Dwarakanathan, V., Ahmad, A., Pandey, P., Kapil, A., Lodha, R., Wig, N.
10.1101/2020.07.31.20166264 — Posted: 2020-08-04
Clinical course and severity outcome indicators among COVID 19 hospitalized patients in relation to comorbidities distribution Mexican cohort
Carrillo, G., Mendez Dominguez, N., Santos Zaldivar, K. D., Rochel Perez, A., Azuela Morales, M., Cuevas Koh, O., Alvarez Baeza, A.
10.1101/2020.07.31.20165480 — Posted: 2020-08-04
A longitudinal survey for genome-based identification of SARS-CoV-2 in sewage water in selected lockdown areas of Lahore city, Pakistan; a potential approach for future smart lockdown strategy
Yaqub, T., Nawaz, M., Shabbir, M. Z., Ali, M. A., Altaf, I., Raza, S., Shabbir, M. A. B., Ashraf, M. A., Aziz, S. Z., Cheema, S. Q., Shah, M. B., Hassan, S., Rafique, S., Sardar, N., Mehmood, A., Aziz, M. W., Fazal, S., Khan, N., Khan, M. T., Attique, M. M., Asif, A., Anwar, M., Awan, N. A., Younis, M. U., Bhatti, M. A., Tahir, Z., Mukhtar, N., Sarwar, H., Rana, M. S.
10.1101/2020.07.31.20165126 — Posted: 2020-08-04
The COVID-19 Consequences of College Class Continuity Calculator: A Tool to Provide Students and Administrators with Estimated Risks of Returning to Campus
Bewick, S., Ludden, E., Robertson, S., Demers, J.
10.1101/2020.07.31.20165761 — Posted: 2020-08-04
SARS-CoV-2 Infection Among Symptom-Free Healthcare Workers
Demmer, R. T., Ulrich, A., Wiggen, T., Strickland, A., Naumchik, B., Kulasingam, S., Stovitz, S. D., Marotz, C., Belda-Ferre, P., Humphrey, G., De Hoff, P., Laurent, L., Kline, S., Knight, R.
10.1101/2020.07.31.20166066 — Posted: 2020-08-04
Analytical Model of COVID-19 for lifting non-pharmaceutical interventions
Jacyna, G., Thompson, J. R., Koehler, M., Slater, D. M.
10.1101/2020.07.31.20166025 — Posted: 2020-08-04
Genomic heterogeneity and clinical characterization of SARS-CoV-2 in Oregon
Dowdell, A. K., Matlock, K., Robinson, F. L., Weerasinghe, R., Rattray, R., Pukay, M., Lathara, M., Harlan, A., Ward, T. R., Campbell, M., Urba, W. J., Srinivasa, G., Bifulco, C. B., Piening, B. D.
10.1101/2020.07.30.20160069 — Posted: 2020-08-04
Making cotton face masks extra-protective by use of impervious cloth as the front layer to restrict flow of aerosols and droplets
Shahane-Kapse, P. L., Shende, M. R., Kar, S., Deshmukh, P., Bhandari, D., Narang, R.
10.1101/2020.07.30.20165563 — Posted: 2020-08-04
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels
Snyder, T. M., Gittelman, R. M., Klinger, M., May, D. H., Osborne, E. J., Taniguchi, R., Zahid, H. J., Kaplan, I. M., Dines, J. N., Noakes, M. N., Pandya, R., Chen, X., Elasady, S., Svejnoha, E., Ebert, P., Pesesky, M. W., De Almeida, P., O'Donnell, H., DeGottardi, Q., Keitany, G., Lu, J., Vong, A., Elyanow, R., Fields, P., Greissl, J., Baldo, L., Semprini, S., Cerchione, C., Mazza, M., Delmonte, O. M., Dobbs, K., Carreno-Tarragona, G., Barrio, S., Imberti, L., Sottini, A., Quiros-Roldan, E., Rossi, C., Biondi, A., Bettini, L. R., D'Angio, M., Bonfanti, P., Tompkins, M. F., Alba, C., Dalgard, C., Sambri, V., Martinelli, G., Goldman, J. D., Heath, J. R., Su, H. C., Notarangelo, L. D., Martinez-Lopez, J., Carlson, J. M., Robins, H. S.
10.1101/2020.07.31.20165647 — Posted: 2020-08-04 Discussion: Onsite
False-Negative Mitigation in Group Testing for COVID-19 Screening
Alizad-Rahvar, A. R., Vafadar, S., Totonchi, M., Sadeghi, M.
10.1101/2020.07.31.20154070 — Posted: 2020-08-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).